Evidence map›Paper›PMID 35147293›Full record

ArticleEndocrinology, diabetes & metabolism2022

Longitudinal changes in blood biomarkers and their ability to predict type 2 diabetes mellitus-The Tromsø study.

Giovanni Allaoui, Charlotta Rylander, Maria Averina, Tom Wilsgaard, Ole-Martin Fuskevåg, Vivian Berg

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Giovanni AllaouiDivision of Diagnostic Services, Department of Laboratory Medicine, University Hospital of North Norway, Tromsø, Norway.
Charlotta RylanderDepartment of Community Medicine, Faculty of Health Sciences, UIT-The Arctic University of Norway, Tromsø, Norway.
Maria AverinaDivision of Diagnostic Services, Department of Laboratory Medicine, University Hospital of North Norway, Tromsø, Norway.
Tom WilsgaardDepartment of Community Medicine, Faculty of Health Sciences, UIT-The Arctic University of Norway, Tromsø, Norway.
Ole-Martin FuskevågDivision of Diagnostic Services, Department of Laboratory Medicine, University Hospital of North Norway, Tromsø, Norway.
Vivian BergDivision of Diagnostic Services, Department of Laboratory Medicine, University Hospital of North Norway, Tromsø, Norway.ORCID 0000-0001-5620-9901
University Hospital of North Norway · NOUiT The Arctic University of Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIdentification of individuals at high risk of developing type 2 diabetes mellitus (T2DM) is important for early prevention of the disease. Once T2DM is established, it is difficult to treat and is associated with cardiovascular complications and increased mortality. We aimed to describe pre- and post-diagnostic changes in blood biomarker concentrations over 30 years in individuals with and without T2DM, and to determine the predictive potential of pre-diagnostic blood biomarkers.

methodsThis nested case-control study included 234 participants in the Tromsø Study who gave blood samples at five time points between 1986 and 2016: 130 did not develop T2DM and were used as controls; 104 developed T2DM after the third time point and were included as cases. After stratifying by sex, we investigated changes in pre- and post-diagnostic concentrations of lipids, thyroid hormones, HbA

resultsCases and controls experienced different longitudinal changes in lipids, free T

conclusionThere were clear differences in blood biomarker concentrations between cases and controls throughout the study, and several blood biomarkers were associated with T2DM. Selected blood biomarkers (lipids, HbA

Indexed as

Diabetes Mellitus, Type 2BiomarkersCase-Control StudiesFemalegamma-GlutamyltransferaseGlucoseHumansLipidsMaleBiomarkersgamma-GlutamyltransferaseGlucoseLipidsbiomarkersblood testhealth servicelongitudinal surveypreventiverisk factorstype 2 diabetes mellitus

Identifiers

PMID35147293
PMCPMC8917864
OpenAlexW4211014851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.